Courtney D. DiNardo, MD - HealthTree Acute Myeloid Leukemia Directory
[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Courtney D. DiNardo, MD

Specialities: Acute Myeloid Leukemia

Spoken languages: English

Clinical Expertise

  • Acute Myeloid Leukemia

About

Dr. DiNardo's research focus is on analysis of isocitrate dehydrogenase (IDH) mutations, serum 2-hydroxyglutarate (2HG) levels, and patient outcomes in AML. Dr. DiNardo is the primary investigator of multiple novel IDH1 or IDH2-targeted therapeutic agents currently in clinical trials. Dr. DiNardo is also involved in the clinical development of the BCL2-inhibitor venetoclax (ABT-199) for myeloid malignancies. She is leading the study of venetoclax in combination with hypomethylating agent therapy for the treatment of newly diagnosed elderly AML patients.

Location

MD Anderson Cancer Center: 1515 Holcombe Blvd, Houston, TX 77030, USA

All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Acute Myeloid Leukemia Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Kura Oncology